An Observation study of Thymoglobuline as Induction therapy in a steriod free maintenance immuno-supressive protocol for INDIAN patients undergoing live donor renal transplantation - OTIS-INDIA.
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- Acronyms OTIS-INDIA
- 21 Mar 2012 Official title amended as reported by Clinical Trials Registry - India.
- 27 Sep 2011 New trial record